| Date | Title | Description |
| 05.10.2024 | Navigating the Waters of Warrant Exercises: A Look at Brain+ and PHI AB | In the world of finance, warrants are like keys to a treasure chest. They offer investors the chance to unlock value by converting them into shares. Recently, two companies, Brain+ and Phase Holographic Imaging (PHI) AB, made headlines with... |
| 04.10.2024 | Phase Holographic Imaging PHI AB receives approx. SEK 5.2 million through warrant exercise | Phase Holographic Imaging PHI AB receives approx. SEK 5.2 million through warrant exercise
Fri, Oct 04, 2024 15:50 CET Report this content
On 3 October 2024, the exercise period for warrants of series TO 4, which were issued in connection w... |
| 30.09.2024 | Notice of Annual General Meeting in Phase Holographic Imaging PHI AB (publ) | Notice of Annual General Meeting in Phase Holographic Imaging PHI AB (publ)
Mon, Sep 30, 2024 16:20 CET Report this content
The shareholders of Phase Holographic Imaging PHI AB (publ), reg. nr. 556542-7811, are hereby invited to attend the ... |
| 28.09.2024 | The Final Countdown: Warrant Expirations and Market Movements | The world of finance is a dance of numbers and timing. Investors are always on the lookout for opportunities, and warrants can be a golden ticket. But like all good things, they come with an expiration date. Recently, two companies, Phase H... |
| 26.09.2024 | The last day of trading in warrants of series TO 4 is on 1 October 2024 | The last day of trading in warrants of series TO 4 is on 1 October 2024
Thu, Sep 26, 2024 09:33 CET Report this content
The 1st of October 2024 is the last day of trading in warrants of series TO 4, which were issued in connection with Phas... |
| 16.09.2024 | PHI announces significant order agreement from Altium for 20 HoloMonitor systems | PHI announces significant order agreement from Altium for 20 HoloMonitor systems
Mon, Sep 16, 2024 13:52 CET Report this content
Phase Holographic Imaging (PHI) is excited to announce a significant order agreement from Altium for 20 HoloMon... |
| 16.09.2024 | Interim Report 1 2024/25 | Interim Report 1 2024/25
Mon, Sep 16, 2024 13:50 CET Report this content
MAY 2024 – JULY 2024
Net sales 1 338 (2 726) KSEK
Operating result before depreciation (EBITDA) -4 733 (-4 299) KSEK
Net result -5 929 (-4 299) KSEK
Earnings per share... |
| 12.09.2024 | The exercise period for warrants of series TO 4 commences today | The exercise period for warrants of series TO 4 commences today
Thu, Sep 12, 2024 08:55 CET Report this content
Today is the first day for the exercise of Phase Holographic Imaging PHI AB's ("PHI" or "Company") warrants ... |
| 11.09.2024 | Navigating the Warrant Landscape: A Look at Diagonal Bio and PHI | In the world of biotechnology, warrants can be a double-edged sword. They offer potential, but they also come with risks. Recently, two companies, Diagonal Bio AB and Phase Holographic Imaging (PHI) AB, announced the exercise prices for the... |
| 11.09.2024 | The exercise price for warrants of series TO 4 has been set to SEK 4.63 per new share | The exercise price for warrants of series TO 4 has been set to SEK 4.63 per new share
Wed, Sep 11, 2024 09:36 CET Report this content
Phase Holographic Imaging PHI AB ("PHI" or "the Company") hereby announces that the ex... |
| 02.09.2024 | Bulletin from extraordinary general meeting in Phase Holographic Imaging PHI AB (publ) | Bulletin from extraordinary general meeting in Phase Holographic Imaging PHI AB (publ)
Mon, Sep 02, 2024 15:24 CET Report this content
Phase Holographic Imaging PHI AB (publ) (“PHI” or the “Company”) held an extraordinary general meeting on... |
| 16.08.2024 | Akobo Minerals and PHI: Two Companies Carving Their Paths in Global Markets | In the bustling world of mining and medical technology, two companies are making headlines. Akobo Minerals is breaking ground in Ethiopia, while Phase Holographic Imaging (PHI) is stepping into the U.S. capital market. Both companies are na... |
| 16.08.2024 | PHI enters the US capital market - shares now also traded on OTCQB | LUND, Sweden, Aug. 16, 2024 /PRNewswire/ -- Phase Holographic Imaging (PHI) is thrilled to announce its official approval for listing on the OTCQB Venture Market in the U.S., with trading commencing yesterday, Thursday, August 15th. This ma... |
| 16.08.2024 | PHI enters the US capital market – shares now also traded on OTCQB | PHI enters the US capital market – shares now also traded on OTCQB
Fri, Aug 16, 2024 08:14 CET Report this content
Phase Holographic Imaging (PHI) is thrilled to announce its official approval for listing on the OTCQB Venture Market in the ... |
| 14.08.2024 | New date: Notice of extraordinary general meeting in Phase Holographic Imaging PHI AB (publ) | New date: Notice of extraordinary general meeting in Phase Holographic Imaging PHI AB (publ)
Wed, Aug 14, 2024 10:32 CET Report this content
Phase Holographic Imaging PHI AB (publ), reg. no. 556542-7811 (the "Company"), will hold ... |
| 14.08.2024 | PHI postpones the extraordinary general meeting until September 2, 2024 | PHI postpones the extraordinary general meeting until September 2, 2024
Wed, Aug 14, 2024 10:00 CET Report this content
The Board of Directors of Phase Holographic Imaging PHI AB (publ) (the "Company"), has decided to postpone the... |
| 22.07.2024 | Notice of extraordinary general meeting in Phase Holographic Imaging PHI AB | Notice of extraordinary general meeting in Phase Holographic Imaging PHI AB
Mon, Jul 22, 2024 10:00 CET Report this content
Phase Holographic Imaging PHI AB (publ), reg. no. 556542-7811 (the "Company"), will hold an extraordinary ... |
| 22.07.2024 | Board member Leland Foster resigns due to personal reasons | Board member Leland Foster resigns due to personal reasons
Mon, Jul 22, 2024 09:59 CET Report this content
Phase Holographic Imaging (PHI), announces the resignation of esteemed board member Leland Foster. Mr. Foster has decided to resign f... |
| 08.07.2024 | PHI applies for listing on OTCQB in the United States | PHI applies for listing on OTCQB in the United States
Mon, Jul 08, 2024 08:52 CET Report this content
Phase Holographic Imaging (PHI) is pursuing a dual listing on the US-based OTCQB Venture Market (“OTCQB”) to provide US-based investors wi... |
| 26.06.2024 | Year-end report 2023/24 | Year-end report 2023/24
Wed, Jun 26, 2024 08:04 CET Report this content FEBRUARY 2024 – APRIL 2024
Net sales 1 686(1 869) KSEK
Operating result before depreciation (EBITDA) -2 719 (-4 240) KSEK
Net result -5 349(-7 717) KSEK
Earnings per sh... |
| 18.06.2024 | PHI bolsters Nordic sales presence with new distribution agreement between Altium and Kem-En-Tec Nordic | PHI bolsters Nordic sales presence with new distribution agreement between Altium and Kem-En-Tec Nordic
Tue, Jun 18, 2024 10:02 CET Report this content
Phase Holographic Imaging (PHI) is pleased to announce a new distribution agreement betw... |
| 13.06.2024 | PHI expands to Spanish and Portuguese markets through Altium's new subcontract with Paralab | PHI expands to Spanish and Portuguese markets through Altium's new subcontract with Paralab
Thu, Jun 13, 2024 11:32 CET Report this content
Phase Holographic Imaging (PHI) is pleased to announce a strategic expansion into the Spanish and Po... |
| 11.06.2024 | PHI partners with University College London to use HoloMonitor in a first clinical research project | PHI partners with University College London to use HoloMonitor in a first clinical research project
Tue, Jun 11, 2024 09:32 CET Report this content
Phase Holographic Imaging (PHI) is excited to announce a strategic partnership with Universi... |
| 04.06.2024 | PHI terminates agreement regarding liquidity provider | PHI terminates agreement regarding liquidity provider
Tue, Jun 04, 2024 09:02 CET Report this content
Phase Holographic Imaging (PHI) today announces that the Company has terminated the liquidity provider agreement with Pareto Securities AB... |
| 23.05.2024 | PHI to BioStock: “It’s the right moment to capitalize on regenerative medicine momentum.” | PHI to BioStock: “It’s the right moment to capitalize on regenerative medicine momentum.”
Thu, May 23, 2024 09:21 CET Report this content
Medtech company Phase Holographic Imaging recently secured a loan facility of SEK 7 million. The compa... |
| 17.05.2024 | PHI secures a loan facility of in total SEK 7 million | PHI secures a loan facility of in total SEK 7 million
Fri, May 17, 2024 08:09 CET Report this content
Phase Holographic Imaging PHI AB ("PHI" or the "Company") announces that the Company has secured a loan facility of in... |
| 02.04.2024 | PHI announces conference schedule for spring 2024 | PHI announces conference schedule for spring 2024
Tue, Apr 02, 2024 10:20 CET Report this content
Phase Holographic Imaging (PHI) is pleased to announce a strategic activity schedule for spring 2024, during which PHI will participate in sel... |
| 27.03.2024 | Interim Report 3 2023/24 | Interim Report 3 2023/24
Wed, Mar 27, 2024 08:20 CET Report this content
NOVEMBER 2023 – January 2024
Net sales 4 873 (3 264) KSEK
Operating result before depreciation (EBITDA) -3 179 (-3 453) KSEK
Net result -5 152 (-4 412) KSEK
Earnings p... |
| 14.03.2024 | Bulletin from extraordinary general meeting in Phase Holographic Imaging PHI AB (publ) | Bulletin from extraordinary general meeting in Phase Holographic Imaging PHI AB (publ)
Thu, Mar 14, 2024 11:05 CET Report this content
On Thursday, March 14, 2024, Phase Holographic Imaging PHI AB (publ), company registration number 556542-... |
| 11.03.2024 | Shaping the future of Regenerative Medicine – PHI’s vision for QPI in Cell Therapy Manufacturing | Shaping the future of Regenerative Medicine – PHI’s vision for QPI in Cell Therapy Manufacturing
Mon, Mar 11, 2024 14:14 CET Report this content
Phase Holographic Imaging (PHI) is pleased to present a comprehensive opinion piece detailing t... |
| 05.03.2024 | New Distributor Partner Manager at Altium set to enhance global sales for PHI | New Distributor Partner Manager at Altium set to enhance global sales for PHI
Tue, Mar 05, 2024 10:46 CET Report this content
Phase Holographic Imaging (PHI) is conveying the news that its global distributor, Altium S.A., has appointed a PH... |
| 26.02.2024 | Notice of extraordinary general meeting in Phase Holographic Imaging PHI AB | Notice of extraordinary general meeting in Phase Holographic Imaging PHI AB
Mon, Feb 26, 2024 10:54 CET Report this content
Phase Holographic Imaging PHI AB (publ), 556542-7811 (the "Company") will hold an extraordinary general me... |
| 07.02.2024 | PHI presents at the Redeye Regenerative Medicine & Cell Therapy 2024 | PHI presents at the Redeye Regenerative Medicine & Cell Therapy 2024
Wed, Feb 07, 2024 14:56 CET Report this content
Phase Holographic Imaging (PHI) announces its participation in the Redeye Regenerative Medicine and Cell Therapy event ... |
| 30.01.2024 | PHI announces extraordinary quarter sales of about 5MSEK — marks the highest ever in Company history | PHI announces extraordinary quarter sales of about 5MSEK — marks the highest ever in Company history
Tue, Jan 30, 2024 15:05 CET Report this content
Phase Holographic Imaging (PHI) is excited to announce that preliminary Q3 net sales are su... |
| 21.12.2023 | Interim Report 2 2023/24 | Interim Report 2 2023/24
Thu, Dec 21, 2023 13:16 CET Report this content AUGUST 2023 – OCTOBER 2023
Net sales 1 225 (2 732) KSEK
Operating result before depreciation (EBITDA) -4 037 (-4 325) KSEK
Net result -5 375 (-5 304) KSEK
Earnings per... |
| 15.12.2023 | PHI appoints Pareto Securities AB to act as a liquidity provider for the Company’s share | PHI appoints Pareto Securities AB to act as a liquidity provider for the Company’s share
Fri, Dec 15, 2023 11:45 CET Report this content
Phase Holographic Imaging (PHI) has appointed Pareto Securities as the Company’s liquidity provider.
Th... |
| 07.12.2023 | PHI granted patent on synthetic antibodies in the EU | PHI granted patent on synthetic antibodies in the EU
Thu, Dec 07, 2023 14:48 CET Report this content
Phase Holographic Imaging (PHI) announces that the Company has been granted a patent on synthetic antibodies from the European Patent Offic... |
| 23.11.2023 | Directed issue registered at the Companies Registration Office | Directed issue registered at the Companies Registration Office
Thu, Nov 23, 2023 11:47 CET Report this content
Phase Holographic Imaging PHI AB (“PHI” or “the Company”) Board of Directors’ proposal on a directed issue to Altium S.A. was res... |
| 15.11.2023 | Bulletin from extraordinary general meeting in Phase Holographic Imaging PHI AB (publ) | Bulletin from extraordinary general meeting in Phase Holographic Imaging PHI AB (publ)
Wed, Nov 15, 2023 11:15 CET Report this content
Phase Holographic Imaging PHI AB (publ) (“PHI” or the “Company”) held an extraordinary general meeting on... |
| 27.10.2023 | Bulletin from the annual general meeting of Phase Holographic Imaging PHI AB (publ) | Bulletin from the annual general meeting of Phase Holographic Imaging PHI AB (publ)
Fri, Oct 27, 2023 17:28 CET Report this content
Phase Holographic Imaging PHI AB (publ) held its annual general meeting on the 27th of October 2023. At the ... |
| 26.10.2023 | PHI’s Board of Directors proposes signing Altium as global distributor partner | PHI’s Board of Directors proposes signing Altium as global distributor partner
Thu, Oct 26, 2023 17:59 CET Report this content
Phase Holographic Imaging (PHI) informs the market that PHI’s Board of Directors decided to propose signing Altiu... |
| 26.10.2023 | Major shareholder acquires PHI’s convertible loan from Formue Nord | Major shareholder acquires PHI’s convertible loan from Formue Nord
Thu, Oct 26, 2023 18:00 CET Report this content
Phase Holographic Imaging (PHI) informs the market that PHI’s largest investor, Altium S.A., has on this day taken over PHI’s... |
| 26.10.2023 | PHI’s Board of Directors proposes a Direct Issue of shares of 9.9 MSEK to Altium | PHI’s Board of Directors proposes a Direct Issue of shares of 9.9 MSEK to Altium
Thu, Oct 26, 2023 17:58 CET Report this content
Phase Holographic Imaging (PHI) informs the market that to raise capital, PHI’s Board of Directors proposes a d... |
| 12.10.2023 | PHI endorses WFIRM as Finalist for NSF’s $160 Million Innovation Grant | PHI endorses WFIRM as Finalist for NSF’s $160 Million Innovation Grant
Thu, Oct 12, 2023 11:28 CET Report this content
Phase Holographic Imaging (PHI) proudly stands behind the Wake Forest Institute for Regenerative Medicine (WFIRM) as they... |
| 20.09.2023 | Interim Report 1 2023/24 | Interim Report 1 2023/24
Wed, Sep 20, 2023 12:18 CET Report this content MAY 2023 – JULY 2023
Net sales 2 726 (2 035) KSEK
Operating result before depreciation (EBITDA) -2 693 (-4 848) KSEK
Net result -4 299 (-5 753) KSEK
Earnings per share... |
| 15.09.2023 | Notice that Interim Report 1 2023/24 will be published on September 20, 2023 | Notice that Interim Report 1 2023/24 will be published on September 20, 2023
Fri, Sep 15, 2023 11:07 CET Report this content
Phase Holographic Imaging announces that the date for publication of Interim Report 1 2023/24 is September 20, 2023... |
| 11.09.2023 | PHI AB annual general meeting moved to 27 October 2023 | PHI AB annual general meeting moved to 27 October 2023
Mon, Sep 11, 2023 11:48 CET Report this content
The board of Phase Holographic Imaging (PHI) AB has decided to move the company’s annual general meeting from 12 October 2023 to 27 Octob... |
| 05.09.2023 | PHI Strengthens Commitment to Regenerative Medicine through ARM and ATMP Sweden Membership | PHI Strengthens Commitment to Regenerative Medicine through ARM and ATMP Sweden Membership
Tue, Sep 05, 2023 09:02 CET Report this content
Phase Holographic Imaging (PHI) becomes a member of the leading international advocacy organization A... |
| 04.07.2023 | European Patent Office intends to grant PHI patent on synthetic antibodies | European Patent Office intends to grant PHI patent on synthetic antibodies
Tue, Jul 04, 2023 08:36 CET Report this content
Phase Holographic Imaging AB (PHI) announces today that the European Patent Office (EPO) intends to grant a patent on... |
| 26.06.2023 | Year-end Report 2022/23 | Year-end Report 2022/23
Mon, Jun 26, 2023 10:33 CET Report this content FEBRUARY 2023 – APRIL 2023
Net sales 1 869 (1 242) KSEK
Operating result before depreciation (EBITDA) -4 240 (-3 173) KSEK
Net result -7 717 (-10 279) KSEK
Earnings per... |
| 21.06.2023 | Notice that Interim Report 4 2022/23 will be published on June 26, 2023 | Notice that Interim Report 4 2022/23 will be published on June 26, 2023
Wed, Jun 21, 2023 14:18 CET Report this content
Phase Holographic Imaging changes the date for publication of Interim Report 4 2022/23 to June 26, 2023.
This decision h... |
| 24.05.2023 | PHI’s new HoloMonitor M4FL premiers at major scientific conferences | PHI’s new HoloMonitor M4FL premiers at major scientific conferences
Wed, May 24, 2023 09:55 CET Report this content
Phase Holographic Imaging (PHI) introduces the HoloMonitor M4FL system to the global scientific community at two major scien... |
| 22.05.2023 | PHI AB’s warrant exercise registered with the Swedish Companies Registration Office | PHI AB’s warrant exercise registered with the Swedish Companies Registration Office
Mon, May 22, 2023 13:35 CET Report this content
Phase Holographic Imaging PHI AB (“PHI” or the “Company”) today announces that the new shares from the exerc... |
| 09.05.2023 | Bulletin from extraordinary general meeting in Phase Holographic Imaging PHI AB (publ) | Bulletin from extraordinary general meeting in Phase Holographic Imaging PHI AB (publ)
Tue, May 09, 2023 17:26 CET Report this content
Phase Holographic Imaging PHI AB (publ) held an extraordinary general meeting on 9 May 2023. The followin... |
| 04.05.2023 | TO 3 Warrants Subscribed to 100 % | TO 3 Warrants Subscribed to 100 %
Thu, May 04, 2023 12:58 CET Report this content
On 2 May 2023, the exercise period for warrants of series TO 3 (“TO 3”), which were issued in connection with Phase Holographic Imaging PHI AB’s (“PHI” or the... |
| 24.04.2023 | Last day of trading in warrants of series TO 3 is 27 April 2023 | Last day of trading in warrants of series TO 3 is 27 April 2023
Mon, Apr 24, 2023 11:10 CET Report this content
Thursday, 27 April 2023, is the last day of trading in warrants of series TO 3, which were issued in connection with Phase Holog... |
| 24.04.2023 | Insider Acquisitions in Phase Holographic Imaging | Insider Acquisitions in Phase Holographic Imaging
Mon, Apr 24, 2023 08:35 CET Report this content
CEO Patrik Eschricht, chairman Peter Egelberg and deputy board member Ann Christine Egelberg has recently acquired additional holdings in Phas... |
| 21.04.2023 | PHI enters into underwriting commitment with Altium in ongoing exercise of TO 3 warrants | PHI enters into underwriting commitment with Altium in ongoing exercise of TO 3 warrants
Fri, Apr 21, 2023 08:04 CET Report this content
Phase Holographic Imaging PHI AB ("PHI" or the "Company") hereby announces that the... |
| 19.04.2023 | Altium S.A. exercised all their obtained warrants TO 3 | Altium S.A. exercised all their obtained warrants TO 3
Wed, Apr 19, 2023 09:27 CET Report this content
Phase Holographic Imaging (PHI) announces that Altium S.A. exercised all their obtained warrants TO 3.
The in total 1491362 exercised TO ... |
| 11.04.2023 | The exercise period for warrants of series TO 3 begins today | The exercise period for warrants of series TO 3 begins today
Tue, Apr 11, 2023 14:27 CET Report this content
Today is the first day of the exercise period for Phase Holographic Imaging PHI AB’s (“PHI” or the “Company”) warrants of series TO... |
| 05.04.2023 | The subscription price for warrants of series TO 3 has been set at SEK 3.78 per share | The subscription price for warrants of series TO 3 has been set at SEK 3.78 per share
Wed, Apr 05, 2023 13:50 CET Report this content
Phase Holographic Imaging PHI AB (“PHI” or the “Company”) hereby announces the subscription price for the ... |
| 28.03.2023 | Interim Report 3 2022/23 | Interim Report 3 2022/23
Tue, Mar 28, 2023 10:45 CET Report this content NOVEMBER 2022 – JANUARY 2023
Net sales 3 264 (2 736) KSEK
Operating result before depreciation (EBITDA) -3 453 (-5 626) KSEK
Net result -4 412 (-6 732) KSEK
Earnings p... |
| 28.03.2023 | Clarification Regarding Potential Collaborations | Clarification Regarding Potential Collaborations
Tue, Mar 28, 2023 08:15 CET Report this content
Scientific institutions like CERN and the US National Institute of Standards of Technology (NIST) actively seek to partner with academia and in... |
| 27.03.2023 | Notice that Interim Report 3 2022/23 will be published already on March 28, 2023 | Notice that Interim Report 3 2022/23 will be published already on March 28, 2023
Mon, Mar 27, 2023 10:35 CET Report this content
Phase Holographic Imaging changes the date for publication of Interim Report 3 2022/23 to March 28, 2023.
This ... |
| 21.03.2023 | PHI creates a subsidiary for the anticipated EU patent concerning synthetic antibodies | PHI creates a subsidiary for the anticipated EU patent concerning synthetic antibodies
Tue, Mar 21, 2023 10:00 CET Report this content
Phase Holographic Imaging (PHI) announces today that the European Patent Office intends to grant applicat... |
| 08.03.2023 | Swiss-based Altium acquires major stake in PHI | Swiss-based Altium acquires major stake in PHI
Wed, Mar 08, 2023 13:00 CET Report this content
Phase Holographic Imaging (PHI) announces that Altium S.A. recently acquired Formue Nord’s entire holdings in PHI of 2 416 679 shares and 1 491 3... |
| 24.01.2023 | PHI expands its global network to India | PHI expands its global network to India
Tue, Jan 24, 2023 15:05 CET Report this content
Phase Holographic Imaging (PHI) has entered a business relationship with Medi Analytika India Pvt. Ltd. This new distributor will represent PHI in the l... |
| 17.01.2023 | PHI Focuses on Biomanufacturing — Appoints New CEO and Chairman | PHI Focuses on Biomanufacturing — Appoints New CEO and Chairman
Tue, Jan 17, 2023 10:16 CET Report this content
The Board of Directors of Phase Holographic Imaging (PHI) has appointed the company’s CFO, Patrik Eschricht, as the new CEO. In ... |
| 21.12.2022 | Interim Report 2 2022/23 | Interim Report 2 2022/23
Wed, Dec 21, 2022 09:09 CET Report this content
AUGUST – OCTOBER
Net sales 2 732 (1 818) KSEK
Operating result before depreciation (EBITDA) -4 325 (-2 733) KSEK
Net result -5 304 (-3 901) KSEK
Earnings per share -0.... |
| 21.11.2022 | PHI IS OPENING A NEW DEVELOPMENT OFFICE IN THE US | PHI IS OPENING A NEW DEVELOPMENT OFFICE IN THE US
Mon, Nov 21, 2022 08:32 CET Report this content
As a result of the newly created alliance for advancing cell-based biomanufacturing which was recently communicated, Phase Holographic Imaging... |
| 14.11.2022 | PHI, SAS, QIAGEN and BioSpherix form Alliance to Advance Cell-based Biomanufacturing | PHI, SAS, QIAGEN and BioSpherix form Alliance to Advance Cell-based Biomanufacturing
Mon, Nov 14, 2022 09:35 CET Report this content
In association with the Wake Forest Institute for Regenerative Medicine, Phase Holographic Imaging (PHI), B... |
| 08.09.2022 | Wake Forest Institute for Regenerative Medicine Welcomes PHI | Wake Forest Institute for Regenerative Medicine Welcomes PHI
Thu, Sep 08, 2022 10:10 CET Report this content
Phase Holographic Imaging (PHI) visits the Wake Forest Institute for Regenerative Medicine (WFIRM) to finalize an agreement concern... |
| 29.06.2022 | Year-end Report 2021/22 | Year-end Report 2021/22
Wed, Jun 29, 2022 08:53 CET Report this content FEBRUARY 2022 – APRIL 2022
Net sales 1 242 (1 910) KSEK
Operating result before depreciation (EBITDA) -3 173 (-5 559) KSEK
Net result -10 279 (-6 784) KSEK
Earnings per... |
| 13.06.2022 | Synthetic antibody patent awarded to PHI by Japan | Synthetic antibody patent awarded to PHI by Japan
Mon, Jun 13, 2022 08:26 CET Report this content
Phase Holographic Imaging AB (PHI) announces today that the Company has been granted a patent concerning synthetic antibodies in Japan. The co... |
| 06.04.2022 | PHI Enters Biomanufacturing Partnership with Wake Forest Institute for Regenerative Medicine | PHI Enters Biomanufacturing Partnership with Wake Forest Institute for Regenerative Medicine
Wed, Apr 06, 2022 10:27 CET Report this content
Phase Holographic Imaging (PHI) and Wake Forest Institute for Regenerative Medicine (WFIRM) recentl... |
| 04.04.2022 | PHI Signs Subscription Commitments with Board Members, CEO and Owners | PHI Signs Subscription Commitments with Board Members, CEO and Owners
Mon, Apr 04, 2022 09:17 CET Report this content
Phase Holographic Imaging (PHI) hereby announces that the company has entered into subscription agreements related to the ... |
| 30.03.2022 | HoloMonitor Fluorescence Now at Novo Nordisk | HoloMonitor Fluorescence Now at Novo Nordisk
Wed, Mar 30, 2022 06:52 CET Report this content
Phase Holographic Imaging (PHI) recently installed a fluorescence-equipped HoloMonitor® system at Novo Nordisk A/S. The installation is part of a s... |
| 17.03.2022 | PHI changes the date for publication of Interim Report 3 2021/22 | PHI changes the date for publication of Interim Report 3 2021/22
Thu, Mar 17, 2022 10:03 CET Report this content
Phase Holographic Imaging changes the date for publication of Interim Report 3 2021/22 to March 21, 2022. The reason for the ch... |
| 15.03.2022 | Continued Sales Growth for PHI | Continued Sales Growth for PHI
Tue, Mar 15, 2022 07:49 CET Report this content
Phase Holographic Imaging’s sales in November – January gained 240 % and amounted to 2.7 (0.8) MSEK. Sales over the past four fiscal quarters (Feb 2021 – Jan 202... |
| 10.03.2022 | PHI Moves to New Premises | PHI Moves to New Premises
Thu, Mar 10, 2022 11:09 CET Report this content
As of today, Phase Holographic Imaging’s registered office is Skiffervägen 48, 224 78 Lund, Sweden. The shift to online sales and marketing has resulted in growing sa... |
| 22.02.2022 | The Board of Directors proposes decision on a rights issue of units and a directed issue of convertibles | The Board of Directors proposes decision on a rights issue of units and a directed issue of convertibles
Tue, Feb 22, 2022 21:47 CET Report this content
The Board of Directors of Phase Holographic Imaging PHI AB (”PHI” or ”the Company”) has... |
| 20.01.2022 | PHI Introduces Non-invasive Fluorescence | PHI Introduces Non-invasive Fluorescence Thu, Jan 20, 2022 09:03 CET
Phase Holographic Imaging (PHI) is currently preparing fluorescence units for its first users. The HoloMonitor add-on fluorescence unit enables medical research laboratori... |
| 29.12.2021 | Interim Report 2 (2021-08-01 – 2021-10-31) | Interim Report 2 (2021-08-01 – 2021-10-31) Wed, Dec 29, 2021 10:34 CET
AUGUST 2021 – OCTOBER 2021
Net sales 1 818 (826) KSEK
Operating result before depreciation (EBITDA) -2 733 (-2 946) KSEK
Net result -3 901 (-4 777) KSEK
Earnings per sha... |
| 29.09.2021 | Interim Report 1 (2021-05-01 – 2021-07-31) | Interim Report 1 (2021-05-01 – 2021-07-31) Wed, Sep 29, 2021 10:26 CET MAY 2021 – JULY 2021
Net sales 2 373 (131) KSEK
Operating result before depreciation (EBITDA) -3 439 (-4 549) KSEK
Net result -4 469 (-6 417) KSEK
Earnings per share -0.... |
| 05.08.2021 | PHI Enters Regenerative Medicine Partnership | PHI Enters Regenerative Medicine Partnership Thu, Aug 05, 2021 09:33 CET
Regenerative medicine and cell-based therapies promise to cure common but severe diseases such as diabetes, Parkinson’s, and several cancer forms. Phase Holographic Im... |
